Epidemiology and Outcomes of Acute Decompensated Heart Failure in Children.


Journal

Circulation. Heart failure
ISSN: 1941-3297
Titre abrégé: Circ Heart Fail
Pays: United States
ID NLM: 101479941

Informations de publication

Date de publication:
04 2020
Historique:
entrez: 18 4 2020
pubmed: 18 4 2020
medline: 18 8 2020
Statut: ppublish

Résumé

Acute decompensated heart failure (ADHF) is a highly morbid condition among adults. Little is known about outcomes in children with ADHF. We analyzed the Pediatric Cardiac Critical Care Consortium registry to determine the epidemiology, contemporary treatments, and predictors of mortality in critically ill children with ADHF. Cardiac intensive care unit (CICU) patients ≤18 years of age meeting Pediatric Cardiac Critical Care Consortium criteria for ADHF were included. ADHF was defined as systolic or diastolic dysfunction requiring continuous vasoactive or diuretic infusion, respiratory support, or mechanical circulatory support. Demographics, diagnosis, therapies, complications, and mortality are described for the cohort. Predictors of CICU mortality were identified using logistic regression. Among 26 294 consecutive admissions (23 centers), 1494 (6%) met criteria for analysis. Median age was 0.93 years (interquartile range, 0.1-9.3 years). Patients with congenital heart disease (CHD) comprised 57% of the cohort. Common therapies included the following: vasoactive infusions (88%), central venous catheters (86%), mechanical ventilation (59%), and high flow nasal cannula (46%). Common complications were arrhythmias (19%), cardiac arrest (10%), sepsis (7%), and acute renal failure requiring dialysis (3%). Median length of CICU stay was 7.9 days (interquartile range, 3-18 days) and the CICU readmission rate was 22%. Overall, CICU mortality was 15% although higher for patients with CHD versus non-CHD (19% versus 11%; ADHF in children is characterized by comorbidities, high mortality rates, and frequent readmission, especially among patients with CHD. Opportunities exist to determine best practices around appropriate use of mechanical support, cardiac arrest prevention, and optimal heart transplantation candidacy to improve outcomes for these patients.

Sections du résumé

BACKGROUND
Acute decompensated heart failure (ADHF) is a highly morbid condition among adults. Little is known about outcomes in children with ADHF. We analyzed the Pediatric Cardiac Critical Care Consortium registry to determine the epidemiology, contemporary treatments, and predictors of mortality in critically ill children with ADHF.
METHODS
Cardiac intensive care unit (CICU) patients ≤18 years of age meeting Pediatric Cardiac Critical Care Consortium criteria for ADHF were included. ADHF was defined as systolic or diastolic dysfunction requiring continuous vasoactive or diuretic infusion, respiratory support, or mechanical circulatory support. Demographics, diagnosis, therapies, complications, and mortality are described for the cohort. Predictors of CICU mortality were identified using logistic regression.
RESULTS
Among 26 294 consecutive admissions (23 centers), 1494 (6%) met criteria for analysis. Median age was 0.93 years (interquartile range, 0.1-9.3 years). Patients with congenital heart disease (CHD) comprised 57% of the cohort. Common therapies included the following: vasoactive infusions (88%), central venous catheters (86%), mechanical ventilation (59%), and high flow nasal cannula (46%). Common complications were arrhythmias (19%), cardiac arrest (10%), sepsis (7%), and acute renal failure requiring dialysis (3%). Median length of CICU stay was 7.9 days (interquartile range, 3-18 days) and the CICU readmission rate was 22%. Overall, CICU mortality was 15% although higher for patients with CHD versus non-CHD (19% versus 11%;
CONCLUSIONS
ADHF in children is characterized by comorbidities, high mortality rates, and frequent readmission, especially among patients with CHD. Opportunities exist to determine best practices around appropriate use of mechanical support, cardiac arrest prevention, and optimal heart transplantation candidacy to improve outcomes for these patients.

Identifiants

pubmed: 32301336
doi: 10.1161/CIRCHEARTFAILURE.119.006101
pmc: PMC7169981
mid: NIHMS1566873
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e006101

Subventions

Organisme : NHLBI NIH HHS
ID : K08 HL116639
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002240
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Eur J Heart Fail. 2010 Mar;12(3):239-48
pubmed: 20156940
Pediatr Cardiol. 2017 Dec;38(8):1672-1679
pubmed: 28852817
J Am Coll Cardiol. 2008 Jul 29;52(5):347-56
pubmed: 18652942
J Heart Lung Transplant. 2016 May;35(5):578-84
pubmed: 27009673
Am Heart J. 2007 Jun;153(6):1021-8
pubmed: 17540205
Cardiol Young. 2011 Jun;21(3):252-9
pubmed: 21310103
Am Heart J. 2005 Feb;149(2):209-16
pubmed: 15846257
J Card Fail. 2013 Oct;19(10):672-7
pubmed: 24125105
Eur Heart J. 2017 Oct 7;38(38):2900-2909
pubmed: 29019615
Circ Heart Fail. 2012 Jul 1;5(4):437-43
pubmed: 22570362
Cardiol Young. 2016 Aug;26(6):1090-6
pubmed: 26358157
Vasc Health Risk Manag. 2017 May 15;13:177-185
pubmed: 28546755
J Am Coll Cardiol. 2009 Feb 17;53(7):557-573
pubmed: 19215829
J Heart Lung Transplant. 2018 Jul;37(7):879-885
pubmed: 29571602
J Pediatr. 2016 Oct;177:153-158.e3
pubmed: 27372394
Cardiol Young. 2015 Jun;25(5):951-7
pubmed: 25167212
J Am Coll Cardiol. 2006 Jan 3;47(1):76-84
pubmed: 16386668
Resuscitation. 2006 Dec;71(3):310-8
pubmed: 17069956
Pediatr Crit Care Med. 2017 Oct;18(10):935-943
pubmed: 28737598
J Card Fail. 2015 Jan;21(1):76-82
pubmed: 25451708
Int J Cardiol. 2016 Oct 15;221:1067-72
pubmed: 27448534
N Engl J Med. 2010 Oct 7;363(15):1419-28
pubmed: 20925544
JACC Heart Fail. 2015 Jan;3(1):70-7
pubmed: 25454394
J Heart Lung Transplant. 2014 Sep;33(9):888-909
pubmed: 25110323
BMC Cardiovasc Disord. 2006 May 25;6:23
pubmed: 16725044
Int J Cardiol. 2014 Dec 20;177(3):840-6
pubmed: 25465830
Interact Cardiovasc Thorac Surg. 2017 Aug 1;25(2):310-316
pubmed: 28486624
Intensive Care Med. 2011 Apr;37(4):619-26
pubmed: 21210078
J Am Coll Cardiol. 2013 Nov 12;62(20):1845-54
pubmed: 23850914
Eur J Heart Fail. 2006 Nov;8(7):697-705
pubmed: 16516552
Crit Care Med. 2006 Apr;34(4):1209-15
pubmed: 16484906

Auteurs

Javier J Lasa (JJ)

Division of Critical Care Medicine (J.J.L., P.A.C., J.E., L.S.S.), Texas Children's Hospital, Baylor College of Medicine, Houston.
Division of Cardiology (J.J.L., A.G.C., J.F.P.), Texas Children's Hospital, Baylor College of Medicine, Houston.

Michael Gaies (M)

Department of Pediatrics, University of Michigan Medical School, Ann Arbor (M.G., K.S.).

Lauren Bush (L)

PC Data Coordinating Center, Michigan Congenital Heart Outcomes Research and Discovery Unit, University of Michigan, Ann Arbor (L.B., W.Z.).

Wenying Zhang (W)

PC Data Coordinating Center, Michigan Congenital Heart Outcomes Research and Discovery Unit, University of Michigan, Ann Arbor (L.B., W.Z.).

Mousumi Banerjee (M)

Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor (M.B.).

Jeffrey A Alten (JA)

Department of Pediatrics, Heart Institute, Cincinnati Children's Hospital Medical Center, OH (J.A.A., A.L.).

Ryan J Butts (RJ)

UT Southwestern Department of Pediatrics, Division of Cardiology, UT Southwestern Medical Center, Dallas, TX (R.J.B.).

Antonio G Cabrera (AG)

Division of Cardiology (J.J.L., A.G.C., J.F.P.), Texas Children's Hospital, Baylor College of Medicine, Houston.

Paul A Checchia (PA)

Division of Critical Care Medicine (J.J.L., P.A.C., J.E., L.S.S.), Texas Children's Hospital, Baylor College of Medicine, Houston.

Justin Elhoff (J)

Division of Critical Care Medicine (J.J.L., P.A.C., J.E., L.S.S.), Texas Children's Hospital, Baylor College of Medicine, Houston.

Angela Lorts (A)

Department of Pediatrics, Heart Institute, Cincinnati Children's Hospital Medical Center, OH (J.A.A., A.L.).

Joseph W Rossano (JW)

Division of Cardiology, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine (J.W.R.).

Kurt Schumacher (K)

Department of Pediatrics, University of Michigan Medical School, Ann Arbor (M.G., K.S.).

Lara S Shekerdemian (LS)

Division of Critical Care Medicine (J.J.L., P.A.C., J.E., L.S.S.), Texas Children's Hospital, Baylor College of Medicine, Houston.

Jack F Price (JF)

Division of Cardiology (J.J.L., A.G.C., J.F.P.), Texas Children's Hospital, Baylor College of Medicine, Houston.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH